Company Profiles

driven by the PitchBook Platform

Promethera Biosciences

Promethera Biosciences
2009 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series C LATEST DEAL TYPE
$11M LATEST DEAL AMOUNT
$81.6M TOTAL AMOUNT RAISED
Description

Developer of products based on stem cell technology to treat liver diseases. The company discovers, develops and commercializes cell therapy products using allogenic progenitor cells harvested from healthy human livers.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
Watson & Crick Hill
Rue Granbonpré, 11
B-1435 Mont-Saint-Guibert
Belgium

+32 (0)1 039 43 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Promethera Biosciences’s full profile, request a free trial.

Promethera Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 28-Oct-2016 $11M $81.6M 0000 Completed Generating Revenue
4. Later Stage VC (Series C) 25-Nov-2014 000.00 000.00 Completed Startup
3. Grant 11-Mar-2014 0000 Completed Startup
2. Early Stage VC (Series B) 28-Mar-2012 $31.2M $39M Completed Startup
1. Early Stage VC (Series A) 29-Oct-2009 $7.8M $7.8M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Promethera Biosciences Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Advanced Technology Materials Corporation Minority 000 0000 000000 0
Boehringer Ingelheim Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
Capital & Croissance Venture Capital Minority 000 0000 000000 0
Cell Innovation Partners Other Minority 000 0000 000000 0
Federal Holding and Investment Company Holding Company Minority 000 0000 000000 0
You’re viewing 5 of 22 investors. Get the full list »

Promethera Biosciences Executive Team (10)

Name Title Board
Seat
Contact
Info
Etienne Sokal Ph.D Founder, Board Member & Chief Innovation and Scientific Officer
John Tchelingerian Ph.D Chief Executive Officer & Chairman of the Board
Frank Hazevoets Chief Financial Officer & Head, Corporate Development
Torsten Hombeck Ph.D Chief Commercial & Strategy Officer
Henrik Luessen Chief Business Officer
You’re viewing 5 of 10 executives. Get the full list »

Promethera Biosciences Board Members (10)

Name Representing Role Since Contact
Info
Alain Parthoens Vesalius Biocapital Partners Board Member 000 0000
Charlie Alexander Promethera Biosciences Board Member & Board Observer 000 0000
Etienne Sokal Ph.D Promethera Biosciences Founder, Board Member & Chief Innovation and Scientific Officer 000 0000
Ilka Wicke Ph.D Boehringer Ingelheim Board Member 000 0000
Ingo Koesfeld Promethera Biosciences Board Member & Board Observer 000 0000

1 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »